Literature DB >> 18486448

The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity.

Jingwei Xie1, Sheela Onnockx, Isabelle Vandenbroere, Chantal Degraef, Christophe Erneux, Isabelle Pirson.   

Abstract

SHIP2 (SH2-containing inositol polyphosphate 5-phosphatase 2) is an ubiquitously expressed phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P(3)) 5-phosphatase which contains various motifs susceptible to mediate protein-protein interaction. In cell models, evidence has been provided that SHIP2 plays a role in insulin and growth factor signaling, cytoskeletal organization, cell adhesion and migration. Herein we describe the c-Jun NH2-terminal kinase (JNK)-interacting protein 1 (JIP1) as a new protein partner of SHIP2. The interaction between SHIP2 and JIP1 was confirmed in both overexpression systems and native cells. Without modifying the association of JIP1 with the MAPKs in the scaffold complex and with no apparent change of Akt phosphorylation, SHIP2 positively modulated the MLK3/JIP1-mediated JNK1 activation. Moreover, SHIP2 positively regulated the tyrosine phosphorylation of JIP1. This up-regulation was prevented by inhibitors of the Src family and Abl kinases, PP2 and Glivec. The effects of SHIP2 on JNK activity and JIP1 tyrosine phosphorylation were independent of the SHIP2 phosphoinositide 5-phosphatase activity, as similar results were obtained when using a SHIP2 catalytic inactive mutant instead of wild-type SHIP2. Together, these data suggest that by its docking properties, SHIP2 can modulate JIP1-mediated JNK pathway signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486448     DOI: 10.1016/j.cellsig.2008.03.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Requirement of JIP1-mediated c-Jun N-terminal kinase activation for obesity-induced insulin resistance.

Authors:  Caroline Morel; Claire L Standen; Dae Young Jung; Susan Gray; Helena Ong; Richard A Flavell; Jason K Kim; Roger J Davis
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

2.  The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus.

Authors:  Shannon McNulty; Kimberly Powell; Christophe Erneux; Daniel Kalman
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

3.  Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt.

Authors:  Yan Ye; Yan Mei Ge; Miao Miao Xiao; Li Mei Guo; Qun Li; Ji Qing Hao; Jie Da; Wang Lai Hu; Xu Dong Zhang; Jiegou Xu; Lin Jie Zhang
Journal:  J Gastroenterol       Date:  2015-07-23       Impact factor: 7.527

4.  SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.

Authors:  Julie De Schutter; Aude Guillabert; Virginie Imbault; Chantal Degraef; Christophe Erneux; David Communi; Isabelle Pirson
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

5.  Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities.

Authors:  Matthew D Blunt; Stephen G Ward
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

Review 6.  PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer.

Authors:  Mariah P Csolle; Lisa M Ooms; Antonella Papa; Christina A Mitchell
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

7.  SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein.

Authors:  Aline Awad; Sokhavuth Sar; Ronan Barré; Clotilde Cariven; Mickael Marin; Jean Pierre Salles; Christophe Erneux; Didier Samuel; Ama Gassama-Diagne
Journal:  Mol Biol Cell       Date:  2013-05-22       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.